Shine taps new general manager for therapeutics division

2019 06 27 17 42 3952 Business Man Handshake 400

Medical isotope firm Shine Medical Technologies has named Chris Vessell as general manager of the company's therapeutics division.

Vessell will oversee a team that is developing lutetium-177 for cancer therapies. He brings more than 25 years of experience in healthcare, manufacturing, and financial services, and he recently served as the U.S. nuclear medicine supply chain lead for GE Healthcare's Pharmaceutical Diagnostics group.

Page 1 of 598
Next Page